+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Oct 2023 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 111
According to our LPI (LP Information) latest study, the global Nicotinamide Riboside Supplements market size was valued at US$ 66 million in 2022. With growing demand in downstream market, the Nicotinamide Riboside Supplements is forecast to a readjusted size of US$ 108.5 million by 2029 with a CAGR of 7.5% during review period.
The research report highlights the growth potential of the global Nicotinamide Riboside Supplements market. Nicotinamide Riboside Supplements are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nicotinamide Riboside Supplements. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nicotinamide Riboside Supplements market.
Key Features:
The report on Nicotinamide Riboside Supplements market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nicotinamide Riboside Supplements market. It may include historical data, market segmentation by Type (e.g., Capsule, Liquid), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nicotinamide Riboside Supplements market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nicotinamide Riboside Supplements market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nicotinamide Riboside Supplements industry. This include advancements in Nicotinamide Riboside Supplements technology, Nicotinamide Riboside Supplements new entrants, Nicotinamide Riboside Supplements new investment, and other innovations that are shaping the future of Nicotinamide Riboside Supplements.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nicotinamide Riboside Supplements market. It includes factors influencing customer ' purchasing decisions, preferences for Nicotinamide Riboside Supplements product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nicotinamide Riboside Supplements market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nicotinamide Riboside Supplements market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nicotinamide Riboside Supplements market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nicotinamide Riboside Supplements industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nicotinamide Riboside Supplements market.
Market Segmentation:
Nicotinamide Riboside Supplements market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Capsule
Liquid
Softgel
Segmentation by application
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thorne
Codeage
ProHealth Longevity
ChromaDex
HPN Nutraceuticals
Cytoplan
solodate
Orgabay
Rossylla
Life Extension
Aesticum
ProHealth
NOW
Double Wood Supplements
aSquared Nutrition
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nicotinamide Riboside Supplements market?
What factors are driving Nicotinamide Riboside Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nicotinamide Riboside Supplements market opportunities vary by end market size?
How does Nicotinamide Riboside Supplements break out type, application?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nicotinamide Riboside Supplements Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nicotinamide Riboside Supplements by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nicotinamide Riboside Supplements by Country/Region, 2018, 2022 & 2029
2.2 Nicotinamide Riboside Supplements Segment by Type
2.2.1 Capsule
2.2.2 Liquid
2.2.3 Softgel
2.3 Nicotinamide Riboside Supplements Sales by Type
2.3.1 Global Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2023)
2.3.2 Global Nicotinamide Riboside Supplements Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nicotinamide Riboside Supplements Sale Price by Type (2018-2023)
2.4 Nicotinamide Riboside Supplements Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Nicotinamide Riboside Supplements Sales by Application
2.5.1 Global Nicotinamide Riboside Supplements Sale Market Share by Application (2018-2023)
2.5.2 Global Nicotinamide Riboside Supplements Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nicotinamide Riboside Supplements Sale Price by Application (2018-2023)
3 Global Nicotinamide Riboside Supplements by Company
3.1 Global Nicotinamide Riboside Supplements Breakdown Data by Company
3.1.1 Global Nicotinamide Riboside Supplements Annual Sales by Company (2018-2023)
3.1.2 Global Nicotinamide Riboside Supplements Sales Market Share by Company (2018-2023)
3.2 Global Nicotinamide Riboside Supplements Annual Revenue by Company (2018-2023)
3.2.1 Global Nicotinamide Riboside Supplements Revenue by Company (2018-2023)
3.2.2 Global Nicotinamide Riboside Supplements Revenue Market Share by Company (2018-2023)
3.3 Global Nicotinamide Riboside Supplements Sale Price by Company
3.4 Key Manufacturers Nicotinamide Riboside Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nicotinamide Riboside Supplements Product Location Distribution
3.4.2 Players Nicotinamide Riboside Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nicotinamide Riboside Supplements by Geographic Region
4.1 World Historic Nicotinamide Riboside Supplements Market Size by Geographic Region (2018-2023)
4.1.1 Global Nicotinamide Riboside Supplements Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nicotinamide Riboside Supplements Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nicotinamide Riboside Supplements Market Size by Country/Region (2018-2023)
4.2.1 Global Nicotinamide Riboside Supplements Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nicotinamide Riboside Supplements Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nicotinamide Riboside Supplements Sales Growth
4.4 APAC Nicotinamide Riboside Supplements Sales Growth
4.5 Europe Nicotinamide Riboside Supplements Sales Growth
4.6 Middle East & Africa Nicotinamide Riboside Supplements Sales Growth
5 Americas
5.1 Americas Nicotinamide Riboside Supplements Sales by Country
5.1.1 Americas Nicotinamide Riboside Supplements Sales by Country (2018-2023)
5.1.2 Americas Nicotinamide Riboside Supplements Revenue by Country (2018-2023)
5.2 Americas Nicotinamide Riboside Supplements Sales by Type
5.3 Americas Nicotinamide Riboside Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nicotinamide Riboside Supplements Sales by Region
6.1.1 APAC Nicotinamide Riboside Supplements Sales by Region (2018-2023)
6.1.2 APAC Nicotinamide Riboside Supplements Revenue by Region (2018-2023)
6.2 APAC Nicotinamide Riboside Supplements Sales by Type
6.3 APAC Nicotinamide Riboside Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nicotinamide Riboside Supplements by Country
7.1.1 Europe Nicotinamide Riboside Supplements Sales by Country (2018-2023)
7.1.2 Europe Nicotinamide Riboside Supplements Revenue by Country (2018-2023)
7.2 Europe Nicotinamide Riboside Supplements Sales by Type
7.3 Europe Nicotinamide Riboside Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nicotinamide Riboside Supplements by Country
8.1.1 Middle East & Africa Nicotinamide Riboside Supplements Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nicotinamide Riboside Supplements Revenue by Country (2018-2023)
8.2 Middle East & Africa Nicotinamide Riboside Supplements Sales by Type
8.3 Middle East & Africa Nicotinamide Riboside Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotinamide Riboside Supplements
10.3 Manufacturing Process Analysis of Nicotinamide Riboside Supplements
10.4 Industry Chain Structure of Nicotinamide Riboside Supplements
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nicotinamide Riboside Supplements Distributors
11.3 Nicotinamide Riboside Supplements Customer
12 World Forecast Review for Nicotinamide Riboside Supplements by Geographic Region
12.1 Global Nicotinamide Riboside Supplements Market Size Forecast by Region
12.1.1 Global Nicotinamide Riboside Supplements Forecast by Region (2024-2029)
12.1.2 Global Nicotinamide Riboside Supplements Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nicotinamide Riboside Supplements Forecast by Type
12.7 Global Nicotinamide Riboside Supplements Forecast by Application
13 Key Players Analysis
13.1 Thorne
13.1.1 Thorne Company Information
13.1.2 Thorne Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.1.3 Thorne Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thorne Main Business Overview
13.1.5 Thorne Latest Developments
13.2 Codeage
13.2.1 Codeage Company Information
13.2.2 Codeage Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.2.3 Codeage Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Codeage Main Business Overview
13.2.5 Codeage Latest Developments
13.3 ProHealth Longevity
13.3.1 ProHealth Longevity Company Information
13.3.2 ProHealth Longevity Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.3.3 ProHealth Longevity Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ProHealth Longevity Main Business Overview
13.3.5 ProHealth Longevity Latest Developments
13.4 ChromaDex
13.4.1 ChromaDex Company Information
13.4.2 ChromaDex Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.4.3 ChromaDex Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 ChromaDex Main Business Overview
13.4.5 ChromaDex Latest Developments
13.5 HPN Nutraceuticals
13.5.1 HPN Nutraceuticals Company Information
13.5.2 HPN Nutraceuticals Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.5.3 HPN Nutraceuticals Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HPN Nutraceuticals Main Business Overview
13.5.5 HPN Nutraceuticals Latest Developments
13.6 Cytoplan
13.6.1 Cytoplan Company Information
13.6.2 Cytoplan Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.6.3 Cytoplan Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cytoplan Main Business Overview
13.6.5 Cytoplan Latest Developments
13.7 solodate
13.7.1 solodate Company Information
13.7.2 solodate Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.7.3 solodate Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 solodate Main Business Overview
13.7.5 solodate Latest Developments
13.8 Orgabay
13.8.1 Orgabay Company Information
13.8.2 Orgabay Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.8.3 Orgabay Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Orgabay Main Business Overview
13.8.5 Orgabay Latest Developments
13.9 Rossylla
13.9.1 Rossylla Company Information
13.9.2 Rossylla Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.9.3 Rossylla Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Rossylla Main Business Overview
13.9.5 Rossylla Latest Developments
13.10 Life Extension
13.10.1 Life Extension Company Information
13.10.2 Life Extension Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.10.3 Life Extension Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Life Extension Main Business Overview
13.10.5 Life Extension Latest Developments
13.11 Aesticum
13.11.1 Aesticum Company Information
13.11.2 Aesticum Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.11.3 Aesticum Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Aesticum Main Business Overview
13.11.5 Aesticum Latest Developments
13.12 ProHealth
13.12.1 ProHealth Company Information
13.12.2 ProHealth Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.12.3 ProHealth Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ProHealth Main Business Overview
13.12.5 ProHealth Latest Developments
13.13 NOW
13.13.1 NOW Company Information
13.13.2 NOW Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.13.3 NOW Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 NOW Main Business Overview
13.13.5 NOW Latest Developments
13.14 Double Wood Supplements
13.14.1 Double Wood Supplements Company Information
13.14.2 Double Wood Supplements Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.14.3 Double Wood Supplements Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Double Wood Supplements Main Business Overview
13.14.5 Double Wood Supplements Latest Developments
13.15 aSquared Nutrition
13.15.1 aSquared Nutrition Company Information
13.15.2 aSquared Nutrition Nicotinamide Riboside Supplements Product Portfolios and Specifications
13.15.3 aSquared Nutrition Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 aSquared Nutrition Main Business Overview
13.15.5 aSquared Nutrition Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Nicotinamide Riboside Supplements Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nicotinamide Riboside Supplements Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Liquid
Table 5. Major Players of Softgel
Table 6. Global Nicotinamide Riboside Supplements Sales by Type (2018-2023) & (K Units)
Table 7. Global Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2023)
Table 8. Global Nicotinamide Riboside Supplements Revenue by Type (2018-2023) & ($ million)
Table 9. Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2023)
Table 10. Global Nicotinamide Riboside Supplements Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Nicotinamide Riboside Supplements Sales by Application (2018-2023) & (K Units)
Table 12. Global Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2023)
Table 13. Global Nicotinamide Riboside Supplements Revenue by Application (2018-2023)
Table 14. Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2023)
Table 15. Global Nicotinamide Riboside Supplements Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Nicotinamide Riboside Supplements Sales by Company (2018-2023) & (K Units)
Table 17. Global Nicotinamide Riboside Supplements Sales Market Share by Company (2018-2023)
Table 18. Global Nicotinamide Riboside Supplements Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Nicotinamide Riboside Supplements Revenue Market Share by Company (2018-2023)
Table 20. Global Nicotinamide Riboside Supplements Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Nicotinamide Riboside Supplements Producing Area Distribution and Sales Area
Table 22. Players Nicotinamide Riboside Supplements Products Offered
Table 23. Nicotinamide Riboside Supplements Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Nicotinamide Riboside Supplements Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Nicotinamide Riboside Supplements Sales Market Share Geographic Region (2018-2023)
Table 28. Global Nicotinamide Riboside Supplements Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Nicotinamide Riboside Supplements Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Nicotinamide Riboside Supplements Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Nicotinamide Riboside Supplements Sales Market Share by Country/Region (2018-2023)
Table 32. Global Nicotinamide Riboside Supplements Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Nicotinamide Riboside Supplements Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Nicotinamide Riboside Supplements Sales by Country (2018-2023) & (K Units)
Table 35. Americas Nicotinamide Riboside Supplements Sales Market Share by Country (2018-2023)
Table 36. Americas Nicotinamide Riboside Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Nicotinamide Riboside Supplements Revenue Market Share by Country (2018-2023)
Table 38. Americas Nicotinamide Riboside Supplements Sales by Type (2018-2023) & (K Units)
Table 39. Americas Nicotinamide Riboside Supplements Sales by Application (2018-2023) & (K Units)
Table 40. APAC Nicotinamide Riboside Supplements Sales by Region (2018-2023) & (K Units)
Table 41. APAC Nicotinamide Riboside Supplements Sales Market Share by Region (2018-2023)
Table 42. APAC Nicotinamide Riboside Supplements Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Nicotinamide Riboside Supplements Revenue Market Share by Region (2018-2023)
Table 44. APAC Nicotinamide Riboside Supplements Sales by Type (2018-2023) & (K Units)
Table 45. APAC Nicotinamide Riboside Supplements Sales by Application (2018-2023) & (K Units)
Table 46. Europe Nicotinamide Riboside Supplements Sales by Country (2018-2023) & (K Units)
Table 47. Europe Nicotinamide Riboside Supplements Sales Market Share by Country (2018-2023)
Table 48. Europe Nicotinamide Riboside Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Nicotinamide Riboside Supplements Revenue Market Share by Country (2018-2023)
Table 50. Europe Nicotinamide Riboside Supplements Sales by Type (2018-2023) & (K Units)
Table 51. Europe Nicotinamide Riboside Supplements Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Nicotinamide Riboside Supplements Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Nicotinamide Riboside Supplements Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Nicotinamide Riboside Supplements Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Nicotinamide Riboside Supplements Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Nicotinamide Riboside Supplements Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Nicotinamide Riboside Supplements Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Nicotinamide Riboside Supplements
Table 59. Key Market Challenges & Risks of Nicotinamide Riboside Supplements
Table 60. Key Industry Trends of Nicotinamide Riboside Supplements
Table 61. Nicotinamide Riboside Supplements Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Nicotinamide Riboside Supplements Distributors List
Table 64. Nicotinamide Riboside Supplements Customer List
Table 65. Global Nicotinamide Riboside Supplements Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Nicotinamide Riboside Supplements Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Nicotinamide Riboside Supplements Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Nicotinamide Riboside Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Nicotinamide Riboside Supplements Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Nicotinamide Riboside Supplements Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Nicotinamide Riboside Supplements Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Nicotinamide Riboside Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Nicotinamide Riboside Supplements Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Nicotinamide Riboside Supplements Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Nicotinamide Riboside Supplements Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Nicotinamide Riboside Supplements Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Nicotinamide Riboside Supplements Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Nicotinamide Riboside Supplements Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Thorne Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 80. Thorne Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 81. Thorne Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Thorne Main Business
Table 83. Thorne Latest Developments
Table 84. Codeage Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 85. Codeage Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 86. Codeage Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Codeage Main Business
Table 88. Codeage Latest Developments
Table 89. ProHealth Longevity Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 90. ProHealth Longevity Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 91. ProHealth Longevity Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. ProHealth Longevity Main Business
Table 93. ProHealth Longevity Latest Developments
Table 94. ChromaDex Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 95. ChromaDex Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 96. ChromaDex Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. ChromaDex Main Business
Table 98. ChromaDex Latest Developments
Table 99. HPN Nutraceuticals Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 100. HPN Nutraceuticals Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 101. HPN Nutraceuticals Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. HPN Nutraceuticals Main Business
Table 103. HPN Nutraceuticals Latest Developments
Table 104. Cytoplan Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 105. Cytoplan Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 106. Cytoplan Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Cytoplan Main Business
Table 108. Cytoplan Latest Developments
Table 109. solodate Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 110. solodate Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 111. solodate Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. solodate Main Business
Table 113. solodate Latest Developments
Table 114. Orgabay Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 115. Orgabay Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 116. Orgabay Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Orgabay Main Business
Table 118. Orgabay Latest Developments
Table 119. Rossylla Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 120. Rossylla Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 121. Rossylla Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Rossylla Main Business
Table 123. Rossylla Latest Developments
Table 124. Life Extension Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 125. Life Extension Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 126. Life Extension Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Life Extension Main Business
Table 128. Life Extension Latest Developments
Table 129. Aesticum Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 130. Aesticum Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 131. Aesticum Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Aesticum Main Business
Table 133. Aesticum Latest Developments
Table 134. ProHealth Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 135. ProHealth Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 136. ProHealth Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. ProHealth Main Business
Table 138. ProHealth Latest Developments
Table 139. NOW Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 140. NOW Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 141. NOW Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. NOW Main Business
Table 143. NOW Latest Developments
Table 144. Double Wood Supplements Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 145. Double Wood Supplements Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 146. Double Wood Supplements Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Double Wood Supplements Main Business
Table 148. Double Wood Supplements Latest Developments
Table 149. aSquared Nutrition Basic Information, Nicotinamide Riboside Supplements Manufacturing Base, Sales Area and Its Competitors
Table 150. aSquared Nutrition Nicotinamide Riboside Supplements Product Portfolios and Specifications
Table 151. aSquared Nutrition Nicotinamide Riboside Supplements Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. aSquared Nutrition Main Business
Table 153. aSquared Nutrition Latest Developments
List of Figures
Figure 1. Picture of Nicotinamide Riboside Supplements
Figure 2. Nicotinamide Riboside Supplements Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicotinamide Riboside Supplements Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Nicotinamide Riboside Supplements Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nicotinamide Riboside Supplements Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Liquid
Figure 11. Product Picture of Softgel
Figure 12. Global Nicotinamide Riboside Supplements Sales Market Share by Type in 2022
Figure 13. Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2023)
Figure 14. Nicotinamide Riboside Supplements Consumed in Online Sales
Figure 15. Global Nicotinamide Riboside Supplements Market: Online Sales (2018-2023) & (K Units)
Figure 16. Nicotinamide Riboside Supplements Consumed in Offline Sales
Figure 17. Global Nicotinamide Riboside Supplements Market: Offline Sales (2018-2023) & (K Units)
Figure 18. Global Nicotinamide Riboside Supplements Sales Market Share by Application (2022)
Figure 19. Global Nicotinamide Riboside Supplements Revenue Market Share by Application in 2022
Figure 20. Nicotinamide Riboside Supplements Sales Market by Company in 2022 (K Units)
Figure 21. Global Nicotinamide Riboside Supplements Sales Market Share by Company in 2022
Figure 22. Nicotinamide Riboside Supplements Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Nicotinamide Riboside Supplements Revenue Market Share by Company in 2022
Figure 24. Global Nicotinamide Riboside Supplements Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Nicotinamide Riboside Supplements Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Nicotinamide Riboside Supplements Sales 2018-2023 (K Units)
Figure 27. Americas Nicotinamide Riboside Supplements Revenue 2018-2023 ($ Millions)
Figure 28. APAC Nicotinamide Riboside Supplements Sales 2018-2023 (K Units)
Figure 29. APAC Nicotinamide Riboside Supplements Revenue 2018-2023 ($ Millions)
Figure 30. Europe Nicotinamide Riboside Supplements Sales 2018-2023 (K Units)
Figure 31. Europe Nicotinamide Riboside Supplements Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Nicotinamide Riboside Supplements Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Nicotinamide Riboside Supplements Revenue 2018-2023 ($ Millions)
Figure 34. Americas Nicotinamide Riboside Supplements Sales Market Share by Country in 2022
Figure 35. Americas Nicotinamide Riboside Supplements Revenue Market Share by Country in 2022
Figure 36. Americas Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2023)
Figure 37. Americas Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2023)
Figure 38. United States Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Nicotinamide Riboside Supplements Sales Market Share by Region in 2022
Figure 43. APAC Nicotinamide Riboside Supplements Revenue Market Share by Regions in 2022
Figure 44. APAC Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2023)
Figure 45. APAC Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2023)
Figure 46. China Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Nicotinamide Riboside Supplements Sales Market Share by Country in 2022
Figure 54. Europe Nicotinamide Riboside Supplements Revenue Market Share by Country in 2022
Figure 55. Europe Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2023)
Figure 56. Europe Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2023)
Figure 57. Germany Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Nicotinamide Riboside Supplements Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Nicotinamide Riboside Supplements Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2023)
Figure 66. Egypt Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Nicotinamide Riboside Supplements Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Nicotinamide Riboside Supplements in 2022
Figure 72. Manufacturing Process Analysis of Nicotinamide Riboside Supplements
Figure 73. Industry Chain Structure of Nicotinamide Riboside Supplements
Figure 74. Channels of Distribution
Figure 75. Global Nicotinamide Riboside Supplements Sales Market Forecast by Region (2024-2029)
Figure 76. Global Nicotinamide Riboside Supplements Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Nicotinamide Riboside Supplements Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Nicotinamide Riboside Supplements Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Nicotinamide Riboside Supplements Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Nicotinamide Riboside Supplements Revenue Market Share Forecast by Application (2024-2029)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
